Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Serum mannose-binding lectin (MBL) concentrations are reduced in non-pregnant women with previous adverse pregnancy outcomes

M. Koucký, K. Malíčková, H. Kopřivová, T. Cindrová-Davies, V. Čapek, A. Pařízek,

. 2020 ; 92 (1) : e12892. [pub] 20200512

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20022995

Grantová podpora
P25/LF1/2 Research Projects PRVOUK
RVO-VFN64165/2012 General University Hospital in Prague

E-zdroje Online Plný text

NLK Free Medical Journals od 1997 do Před 1 rokem
Medline Complete (EBSCOhost) od 1972-01-01 do Před 1 rokem
Wiley Free Content od 1997 do Před 1 rokem

Mannose-binding lectin (MBL) is an important component of the innate immunity, and it is responsible not only for opsonization of micro-organisms, but also for efferocytosis. The aim of this study was to investigate whether MBL concentrations and lectin complement pathway activity are altered in non-pregnant women with previous adverse pregnancy outcomes. Patients were divided into four groups on the basis of their history of pregnancy complications, including control patients who had uncomplicated pregnancies and term deliveries (control, n = 33), and three groups of patients with a history of pregnancy complications, including preterm labour (n = 29), recurrent miscarriage (n = 19) or unexplained intrauterine foetal death (IUFD; n = 17). All women enrolled in the study had an interval of three to six months following their previous pregnancy, and they agreed to have a blood sample taken. We found significantly higher MBL concentrations and functional activity of the lectin complement pathway in healthy controls who had previous uneventful term pregnancies (1341 ng/mL; activity 100% (IQR: 62%-100%)), compared to women with the history of IUFD (684 ng/mL, P = .008; activity 8.5% (IQR: 0%-97.8%), P = .011), recurrent miscarriage (524 ng/mL, P = .022; activity 44% (IQR: 4%-83%), P = .011) or preterm labour (799 ng/mL, P = .022; activity 62.5% (IQR: 0%-83%), P = .003). Our results suggest that inadequate function of the complement lectin pathway is associated with a higher risk of preterm labour, recurrent miscarriage and unexplained intrauterine foetal death.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20022995
003      
CZ-PrNML
005      
20201214125103.0
007      
ta
008      
201125s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/sji.12892 $2 doi
035    __
$a (PubMed)32335925
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Koucký, Michal $u Department of Gynecology and Obstetrics of the First Faculty of Medicine and General Teaching Hospital, Charles University in Prague, Prague, Czech Republic.
245    10
$a Serum mannose-binding lectin (MBL) concentrations are reduced in non-pregnant women with previous adverse pregnancy outcomes / $c M. Koucký, K. Malíčková, H. Kopřivová, T. Cindrová-Davies, V. Čapek, A. Pařízek,
520    9_
$a Mannose-binding lectin (MBL) is an important component of the innate immunity, and it is responsible not only for opsonization of micro-organisms, but also for efferocytosis. The aim of this study was to investigate whether MBL concentrations and lectin complement pathway activity are altered in non-pregnant women with previous adverse pregnancy outcomes. Patients were divided into four groups on the basis of their history of pregnancy complications, including control patients who had uncomplicated pregnancies and term deliveries (control, n = 33), and three groups of patients with a history of pregnancy complications, including preterm labour (n = 29), recurrent miscarriage (n = 19) or unexplained intrauterine foetal death (IUFD; n = 17). All women enrolled in the study had an interval of three to six months following their previous pregnancy, and they agreed to have a blood sample taken. We found significantly higher MBL concentrations and functional activity of the lectin complement pathway in healthy controls who had previous uneventful term pregnancies (1341 ng/mL; activity 100% (IQR: 62%-100%)), compared to women with the history of IUFD (684 ng/mL, P = .008; activity 8.5% (IQR: 0%-97.8%), P = .011), recurrent miscarriage (524 ng/mL, P = .022; activity 44% (IQR: 4%-83%), P = .011) or preterm labour (799 ng/mL, P = .022; activity 62.5% (IQR: 0%-83%), P = .003). Our results suggest that inadequate function of the complement lectin pathway is associated with a higher risk of preterm labour, recurrent miscarriage and unexplained intrauterine foetal death.
650    _2
$a dospělí $7 D000328
650    _2
$a lektinová dráha komplementu $x imunologie $7 D037582
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a přirozená imunita $x imunologie $7 D007113
650    _2
$a lektin vázající mannosu $x krev $7 D037601
650    _2
$a těhotenství $7 D011247
650    _2
$a komplikace těhotenství $x krev $x epidemiologie $7 D011248
650    _2
$a výsledek těhotenství $7 D011256
650    _2
$a prospektivní studie $7 D011446
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
700    1_
$a Malíčková, Karin $u Institute of Medical Biochemistry and Laboratory Diagnostics of the First Faculty of Medicine and General Teaching Hospital, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Kopřivová, Helena $u Institute of Medical Biochemistry and Laboratory Diagnostics of the First Faculty of Medicine and General Teaching Hospital, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Cindrová-Davies, Tereza $u Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
700    1_
$a Čapek, Václav
700    1_
$a Pařízek, Antonín $u Department of Gynecology and Obstetrics of the First Faculty of Medicine and General Teaching Hospital, Charles University in Prague, Prague, Czech Republic.
773    0_
$w MED00010600 $t Scandinavian journal of immunology $x 1365-3083 $g Roč. 92, č. 1 (2020), s. e12892
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32335925 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125103 $b ABA008
999    __
$a ok $b bmc $g 1595314 $s 1113671
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 92 $c 1 $d e12892 $e 20200512 $i 1365-3083 $m Scandinavian journal of immunology $n Scand J Immunol $x MED00010600
GRA    __
$a P25/LF1/2 $p Research Projects PRVOUK
GRA    __
$a RVO-VFN64165/2012 $p General University Hospital in Prague
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...